Baye Dagnew Mekonnon | Medicine and Dentistry | Best Researcher Award

Posted on by Phenomenological Research Awards

Dr. Baye Dagnew Mekonnon | Medicine and Dentistry | Best Researcher Award 

Doctor at Menzies institute for Medical Research | Australia

Dr. Baye Dagnew Mekonnon is a dedicated medical researcher and academic with expertise in epidemiology, public health, and chronic disease management, particularly focusing on sleep, pain, and quality of life in neurological and metabolic conditions. He earned his Ph.D. in Medical Studies (Epidemiology) from the University of Tasmania, Australia, where his thesis on “Sleep and Pain in Multiple Sclerosis” produced five original research contributions and advanced the understanding of symptom burden in people with multiple sclerosis. He also holds a Master of Science degree in Medical Physiology from Jimma University, Ethiopia, and a Bachelor of Science in Public Health from the University of Gondar. Over the course of his career, he has accumulated more than eight years of teaching, clinical, and research experience, serving as a lecturer, MSc supervisor, and internal examiner at the University of Gondar before joining the Menzies Institute for Medical Research in Australia. His professional journey includes active involvement in large-scale projects such as the Australian Multiple Sclerosis Longitudinal Study and global collaborations through the Global Burden of Disease initiative. Dr. Baye Dagnew Mekonnon has authored over 70 peer-reviewed publications in reputable journals, contributing significantly to the fields of epidemiology, neurology, sleep research, and chronic disease epidemiology, with his work widely cited in international literature. His methodological expertise spans survey design, advanced statistical modeling, longitudinal and mixed-methods research, and data analysis using multiple software platforms, alongside substantial experience in ethics applications and governance. His research interests lie in exploring the intersections between sleep, pain, comorbidities, and mental health in chronic disease populations, with an emphasis on translating evidence into patient-centered interventions and health policies. In addition, he has engaged in research translation projects, including the development of educational resources for people with multiple sclerosis, while also presenting his work at national and international conferences. Dr. Baye Dagnew Mekonnon’s scholarship demonstrates a strong balance of academic rigor, innovation, and community relevance, underpinned by a collaborative and impact-driven approach. With his proven research excellence, teaching experience, and international collaborations, he is poised to continue making influential contributions to global health research, advancing understanding of complex chronic conditions, and shaping the future of epidemiological studies worldwide.

Profile: Google Scholar

Featured Publications:

  • Dagnew, B. (2020). Global burden of cardiovascular diseases and risk factors, 1990–2019: update from the GBD 2019 study. Journal of the American College of Cardiology, Cited by: 11,252.

  • Dagnew, B. (2021). Global, regional, and national burden of stroke and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. The Lancet Neurology, Cited by: 3,050.

  • Dagnew, B. (2021). Trends in prevalence of blindness and distance and near vision impairment over 30 years: an analysis for the Global Burden of Disease Study. The Lancet Global Health, Cited by: 1,104.

  • Dagnew, B. (2021). Hearing loss prevalence and years lived with disability,findings from the Global Burden of Disease Study 2019. The Lancet, Cited by: 1,051.

  • Dagnew, B. (2020). The burden of unintentional drowning: global, regional and national estimates of mortality from the Global Burden of Disease 2017 Study. Injury Prevention, 26, Cited by: 268.

  • Dagnew, B. (2021). Global, regional, and national burden of respiratory tract cancers and associated risk factors from 1990 to 2019: a systematic analysis for the Global Burden of Disease Study 2019. The Lancet Respiratory Medicine, Cited by: 218.

  • Dagnew, B. (2021). Measuring routine childhood vaccination coverage in 204 countries and territories, a systematic analysis for the Global Burden of Disease Study 2020, Release 1. The Lancet, Cited by: 188.

Luca Roncati | Medicine and Dentistry | Best Researcher Award

Posted on by Phenomenological Research Awards

Prof. Luca Roncati | Medicine and Dentistry | Best Researcher Award  

Professor at Link Campus University | Italy

Prof. Luca Roncati is an accomplished Italian physician-scientist, pathologist, and academic who has made outstanding contributions to medicine and dentistry through his pioneering research, teaching, and clinical leadership. He earned his Ph.D. in Pathology, building a solid academic foundation that has enabled him to excel in translational research across multiple domains including senology, gynecologic oncology, gynecopathology, and hematopathology. Currently, he serves as a Full Professor of Pathology at Link Campus University in Rome and as Head of the Women’s Health Department at the European Institute of Dermatology in Milan, where he integrates patient care with innovative research. His professional experience also extends to forensic pathology and editorial responsibilities, highlighting his multidisciplinary expertise and leadership in the scientific community. Prof. Luca Roncati’s research interests span cancer biology, nanopathology, women’s health, and infectious diseases, with significant contributions to the understanding of COVID-19 pathology, exemplified by several highly cited publications. His skills include advanced diagnostic pathology, molecular biology, nanotechnology applications in medicine, and academic mentorship, as well as the ability to translate complex findings into practical healthcare solutions. With over 227 publications, 1,726 citations by 1,064 documents, and an h-index of 23, his academic output reflects sustained global impact and recognition. His innovative work includes the description of the Roncati-Manenti triad and T rex lymphoma, and his authorship of more than 280 peer-reviewed publications in high-impact journals has positioned him as a global thought leader. Prof. Luca Roncati has received numerous honors as an award-winning author and inventor of anti-cancer patents, underscoring his capacity to merge science with innovation. In conclusion, Prof. Luca Roncati’s distinguished academic record, clinical leadership, and groundbreaking contributions to oncology, nanopathology, and women’s health make him a leading figure in medicine whose continued work promises to advance medical research, patient care, and global health standards.

Profile: Scopus

Featured Publications:

  1. Roncati, L. (2020). The COVID-19 syndrome: a clinical perspective. Clinical Immunology, 215, 108487.

  2. Roncati, L. (2020). Endothelial–platelet interactions in COVID-19. Annals of Hematology, 99(9), 1955–1956.

  3. Roncati, L. (2020). T rex lymphoma: a novel hematologic entity. Current Medical Research and Opinion, 36(3), 511–514.

  4. Roncati, L. (2017). Nanopathology: the health impact of nanoparticles. Nanotoxicology, 11(7), 884–888.

  5. Roncati, L. (2016). The Roncati–Manenti triad in gynecologic oncology. International Journal of Gynecological Cancer, 26(8), 1584–1585.

  6. Roncati, L. (2019). The forensic challenges in the study of nanoparticle exposure. Forensic Science International, 301, 309–315.

  7. Roncati, L. (2018). Molecular pathology insights into breast cancer. Pathology Research and Practice, 214(12), 2000–2005.